Kang Ding
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kang Ding has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Da‐Chao Xu
Department of Colorectal Surgery, The Third Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
1 shared publicationHui Zhang
Clinical Lab,The Third Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
1 shared publicationJian Fang
Department of Colorectal Surgery, The Third Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
1 shared publicationMeng Li
First Clinical Medical College,Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
1 shared publicationMeng‐Ling Cai
First Clinical Medical College,Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
1 shared publicationShi‐Cai Huang
First Clinical Medical College,Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
1 shared publication
Latest Publications
- 11 December 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (4) , 5687-5694
β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria
In this article, we aim to examine the novel effects of β‐sitosterol on murine experimental colitis. β‐Sitosterol significantly reduces the weight loss, colon length, and alleviated microscopic appearances of colitis induced by dextran sulfate sodium. This compound also decreases the levels of TNF‐α, IL‐6, and IL‐1β in intestinal tissue of mice with experimental colitis in a concentration‐dependent manner. β‐Sitosterol treatment to intestinal epithelial cells significantly increases expression of antimicrobial peptides and reduces survival of intracellular Salmonella typhimurium. These results showed the multiple effects of β‐sitosterol against pathogenic bacteria for a novel approach to the treatment of colonic inflammation.
- 11 December 2018
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (4) , 5687-5694
β‐Sitosterol improves experimental colitis in mice with a target against pathogenic bacteria
In this article, we aim to examine the novel effects of β‐sitosterol on murine experimental colitis. β‐Sitosterol significantly reduces the weight loss, colon length, and alleviated microscopic appearances of colitis induced by dextran sulfate sodium. This compound also decreases the levels of TNF‐α, IL‐6, and IL‐1β in intestinal tissue of mice with experimental colitis in a concentration‐dependent manner. β‐Sitosterol treatment to intestinal epithelial cells significantly increases expression of antimicrobial peptides and reduces survival of intracellular Salmonella typhimurium. These results showed the multiple effects of β‐sitosterol against pathogenic bacteria for a novel approach to the treatment of colonic inflammation.